Sun Pharma arm-SPARC, Bioprojet ink licensing pact for auto-immune diseases drug SCD-044 Medical Dialogues Bureau20 Dec 2019 9:45 AM ISTSPARC and Bioprojet co-owned all SCD-044 related IP, developed through a research collaboration targeting Sphingosine-1-Phosphate Receptors to treat...
Merck Ebola vaccine Ervebo gets USFDA okay Medical Dialogues Bureau20 Dec 2019 9:30 AM ISTIn November, Merck received approval from the European Commission to market Ervebo, less than a month after a European medicines panel backed the...
FTC seeks to block Illumina from buying PacBio Medical Dialogues Bureau20 Dec 2019 9:00 AM ISTThe Federal Trade Commission said in a statement that it filed the antitrust complaint because of concern that Illumina wanted the deal in order to...
NPPA show-cause notices to Sun Pharma, Glenmark, Abbott, Lupin for self-exemption from price cap for anti-diabetic drugs Farhat Nasim19 Dec 2019 2:26 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has called for action and issued show-cause notices to drug giants including Sun...
Withdraw decision of NPPA increasing ceiling price of essential life-saving drug; CPI writes to PM Medical Dialogues Bureau19 Dec 2019 1:13 PM ISTIn the letter addressed to Prime Minister Modi, Viswam said, "On behalf of the common people in India, I request you to take immediate steps to...
Indian pharma sector to grow at 10-12 pc during FY19-22, says ICRA Medical Dialogues Bureau19 Dec 2019 10:00 AM ISTIcra, however, warned that while the US growth is expected to remain at high single-digit to low double-digit, it will face headwinds given the...
Astellas, Seattle Genetics cancer drug Padcev gets speedy nod from USFDA Medical Dialogues Bureau19 Dec 2019 9:30 AM ISTThe drug, Padcev, is the first USFDA approved treatment in the United States for patients with advanced or metastatic urothelial cancer, Astellas...
Biohaven Pharma acute migraine drug Vazegepant succeeds in study Medical Dialogues Bureau19 Dec 2019 9:15 AM ISTVazegepant is the first CGRP treatment delivered in an intranasal formulation, which benefits patients uncomfortable with needles, Biohaven Pharma...
Purdue Pharma CEO bonus opposed by senators Medical Dialogues Bureau19 Dec 2019 8:59 AM IST"Purdue Pharma is still more concerned with motivating high-level employees to sell more drugs than it is with public health or helping states...
Hetero launches HIV drug Taffic in India post DCGI nod Medical Dialogues Bureau18 Dec 2019 11:30 AM ISTHetero Lab's antiretroviral combination drug- Taffic is a generic version of Gilead's Biktarvy and has been approved by the Drug Controller General of...
Lupin arm Nanomi BV completes Kyowa divestiture to Unison Medical Dialogues Bureau18 Dec 2019 9:45 AM IST"The transaction generates post-tax net cash inflow of nearly 33,429 million Japanese yen (about Rs 2,158 crore) and significantly strengthens Lupin's...
GSK seeks USFDA nod for myeloma drug Belantamab Mafodotin Medical Dialogues Bureau18 Dec 2019 9:25 AM ISTThe trial was testing GSK's experimental multiple myeloma drug Belantamab Mafodotin, also known as GSK2857916, in patients who had received four to...
